Editorial: Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms
Front Pharmacol
.
2022 Nov 22:13:1088908.
doi: 10.3389/fphar.2022.1088908.
eCollection 2022.
Authors
Tharmarajan Ramprasath
1
,
Nandakumar Natarajan
2
,
Jacob Gopas
3
,
Ramasamy Subbiah
4
,
Peramaiyan Rajendran
5
,
Sakthivel Vaiyapuri
6
Affiliations
1
Center for Molecular and Translational Medicine, Georgia State University, Atlanta, GA, United States.
2
The University of Texas Health Science Center at Tyler, Tyler, TX, United States.
3
Ben-Gurion University of the Negev, Beersheba, Israel.
4
Department of Biochemistry, School of Biological Sciences, Madurai Kamaraj University Madurai, Madurai, India.
5
Department of Biological Sciences, College of Science, King Faisal University, Al Ahsa, Saudi Arabia.
6
University of Reading, Reading, United Kingdom.
PMID:
36506520
PMCID:
PMC9731149
DOI:
10.3389/fphar.2022.1088908
No abstract available
Keywords:
NF-κB; NLRP3; inflammation; small molecules; vascular diseases.
Publication types
Editorial